Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns.
Share this article
Corporate
Score 85
Bullish
Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns
Mar 25, 2026 13:14 UTC
MRK, XLV, IHF
Short term
Related Articles
Score 75
Bullish
DBS Joins Buzzing India ECM Space With Mandate in $1 Billion IPO
Mar 27, 02:00
Score 85
Bullish
Pop Mart Launches Largest Ever Buyback After Record Stock Plunge
Mar 27, 01:16
Score 45
Ace Robotics Chairman on Embodied AI, Robotics
Mar 27, 00:48
Score 65
Bullish
TDR, I Squared Are Said to Select Banks for Aggreko’s US IPO
Mar 27, 00:26
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.